Drug: Romosozumab
Device: Circadian Effective Lighting
Device: Circadian Ineffective Lightning (CIL)
Biological: CB-011
Drug: VP301
Drug: Elranatamab
Drug: Carfilzomib
Drug: KTX-1001
Drug: Modakafusp Alfa
Drug: Daratumumab
Biological: Manufactured Anti-BCMA CAR-T cells
Drug: Fludarabine
Drug: Cyclophosphamide
Drug: GPC-100
Drug: Propranolol
Drug: G-CSF
Drug: Iberdomide
Drug: Elotuzumab
Drug: Dexamethasone
Drug: Belantamab Mafodotin
Drug: Nirogacestat
Drug: Modakafusp alfa
Drug: Lenalidomide
Drug: Bortezomib
Drug: Carfilzomib
Drug: Daratumumab
Drug: Pomalidomide
Drug: CC-92480
Drug: Carfilzomib
Drug: Dexamethasone
Drug: Cevostamab
Drug: Tocilizumab
Drug: Selinexor
Drug: Venetoclax
Drug: Dexamethasone
Drug: CC-92480
Drug: Pomalidomide
Drug: Bortezomib
Drug: Dexamethasone
Drug: Teclistamab
Drug: Lenalidomide
Drug: Dexamethasone
Drug: Talquetamab
Drug: Daratumumab
Drug: Pomalidomide
Drug: Dexamethasone
Drug: Iberdomide
Drug: Daratumumab
Drug: Dexamethasone
Drug: Carfilzomib
Biological: MCARH125
Biological: MCARH109
Drug: Budesonide EC
Drug: Placebo
Biological: CART-ddBCMA
Biological: Ide-cel (bb2121)
Drug: CC-92480
Drug: Tazemetostat
Drug: BMS-986158
Drug: Trametinib
Drug: Dexamethasone
Drug: Iberdomide
Drug: Cilta-cel
Drug: Lymphodepleting Therapy (Cyclophosphamide and Fludarabine)
Drug: Isatuximab
Other: Standard Procedures
Drug: Isatuximab
Drug: Lenalidomide
Drug: Talquetamab
Drug: Teclistamab
Drug: PD-1 Inhibitor
Drug: Radiation Therapy
Drug: ABBV-453
Drug: EOS884448
Drug: Iberdomide
Drug: Dexamethasone
Drug: ABBV-383
Drug: Dexamethasone
Drug: Lenalidomide
Drug: Pomalidomide
Drug: Nirogacestat
Drug: Daratumumab
Drug: ORIC-533
Drug: Carfilzomib
Drug: Iberdomide
Drug: Oral Dexamethasone
Other: Discontinue maintenance therapy SOC
Biological: Pembrolizumab
Drug: FT576 (Allogenic CAR NK cells with BCMA expression)
Drug: Cyclophosphamide
Drug: Fludarabine
Drug: Daratumumab
Drug: Iberdomide
Biological: PHE885
Drug: BMF-219
Drug: Isatuximab
Drug: Lenalidomide
Drug: Dexamethasone
Drug: TTI-622
Drug: Daratumumab Hyaluronidase-fihj
Drug: Plinabulin
Drug: EZM0414
Drug: Belantamab mafodotin
Drug: Descartes-25
Drug: Elranatamab + Nirogacestat
Drug: Elranatamab + lenalidomide + dexamethasone
Drug: Daratumumab
Drug: Pomalidomide
Drug: Dexamethasone
Drug: Bortezomib
Drug: Teclistamab
Drug: Belantamab mafodotin
Drug: Belantamab mafodotin
Drug: Talquetamab
Drug: Carfilzomib
Drug: Daratumumab SC
Drug: Lenalidomide
Drug: Pomalidomide
Drug: Lenalidomide and bb2121
Drug: Selinexor
Drug: Elotuzumab
Drug: Pomalidomide
Drug: Dexamethasone Oral
Drug: NMS-03597812
Drug: NMS-03597812 + dexamethasone
Drug: TriPRIL CAR T Cells
Drug: Cyclophosphamide
Drug: Fludarabine
Drug: Elranatamab
Drug: Elranatamab+ dexamethasone
Drug: Evomela
Device: Next Generation Sequencing
Drug: Prochlorperazine
Drug: Acetaminophen
Drug: Diphenhydramine
Biological: STI-1492
Drug: Elotuzumab
Drug: Belantamab mafodotin
Genetic: ALLO-605
Biological: ALLO-647
Drug: Fludarabine
Drug: Cyclophosphamide
Drug: DaraVRD
Drug: Dexamethasone
Drug: Daratumumab
Drug: Bortezomib
Drug: Iberdomide
Drug: Iberdomide
Drug: Iberdomide
Drug: Siltuximab
Drug: CC-92328
Drug: BGB-11417
Drug: Dexamethasone
Drug: Carfilzomib
Biological: P-BCMA-ALLO1 CAR-T cells
Drug: Rimiducid
Drug: APG-2575+ Pd
Drug: APG-2575 + DRd
Drug: Dexamethasone
Drug: Carfilzomib
Biological: Daratumumab
Drug: Selinexor
Drug: Pomalidomide
Drug: Daratumumab
Drug: Carfilzomib
Drug: Dexamethasone
Drug: Bortezomib
Drug: Dexamethasone
Drug: Lenalidomide
Drug: Cilta-cel
Drug: Cyclophosphamide
Drug: Fludarabine
Behavioral: CHAMPS-II adapted to adults 60+ years in HCT setting
Other: Survivorship education active control
Drug: Belantamab Mafodotin, Cyclophosphamide and Dexamethasone
Drug: Magrolimab
Drug: Daratumumab
Drug: Pomalidomide
Drug: Dexamethasone
Drug: Bortezomib
Drug: Carfilzomib
Biological: LAVA-051
Drug: HDP-101
Biological: BB2121
Drug: CC-220
Drug: BMS-986405
Drug: Metformin XR
Other: Placebo
Drug: Isatuximab (for run-in portion)
Drug: Isatuximab (for expansion)
Drug: Pomalidomide
Drug: Elotuzumab
Drug: Dexamethasone
Biological: GEN3014
Drug: Daratumumab
Drug: Carfilzomib, Lenalidomide, Dexamethasone, Belantamab Mafodotin
Drug: Selinexor
Drug: Dexamethasone Oral
Drug: Daratumumab
Drug: Lenalidomide
Drug: TAK-981
Drug: Mezagitamab
Drug: Daratumumab and Hyaluronidase-fihj
Drug: Daratumumab
Drug: Bortezomib
Drug: Lenalidomide
Drug: Dexamethasone
Drug: AB308
Drug: Zimberelimab
Drug: LP-118
Drug: CFT7455
Drug: Dexamethasone Oral
Drug: Curcumin plus Piperine
Drug: VOB560
Drug: MIK665
Drug: Daratumumab
Drug: Pomalidomide
Drug: All-trans retinoic acid
Drug: Dexamethasone
Drug: CC-95266
Drug: Fludarabine
Drug: Cyclophosphamide
Drug: Bendamustine
Drug: Selinexor 60 MG
Drug: Selinexor 80 MG
Drug: Selinexor 100 MG
Drug: Carfilzomib
Drug: Pomalidomide
Drug: Daratumumab
Drug: Dexamethasone
Drug: Isatuximab
Drug: Lenalidomide
Drug: Bortezomib Injection
Drug: Dexamethasone
Drug: Daratumumab
Drug: Lenalidomide
Drug: Dexamethasone
Combination Product: CIML NK Cells plus KP1237 and low dose IL-2
Drug: FT538
Drug: Cyclophosphamide
Drug: Fludarabine
Drug: Daratumumab
Drug: Elotuzumab
Drug: INCB000928
Drug: Selinexor
Drug: Lenalidomide
Drug: Methylprednisolone
Drug: Lenalidomide
Drug: Daratumumab
Behavioral: Questionnaires
Other: Dietary Intervention
Drug: Belantamab mafodotin
Drug: Pomalidomide
Drug: Dexamethasone
Drug: Bortezomib
Procedure: Autologous Hematopoietic Stem Cell Transplantation
Drug: Melphalan
Other: Questionnaire Administration
Other: Acupuncture
Drug: opioid
Other: Assessments
Drug: Carfilzomib
Drug: Isatuximab
Drug: Lenalidomide
Drug: Dexamethasone
Drug: Tasquinimod
Drug: IRd chemotherapy
Drug: Belantamab mafodotin
Drug: Belantamab mafodotin
Drug: ION251
Drug: Dose escalation: COM902 monotherapy.
Combination Product: Evaluation of safety/tolerability: COM902 in combination with COM701 (both at the RDFE)
Drug: Cohort expansion: COM902 (RDFE) monotherapy.
Drug: Cohort expansion: COM902 in combination with COM701 (both at the RDFE).
Combination Product: Cohort expansion: Triplet combination of COM902 + COM701 + Pembrolizumab.
Biological: PHE885
Drug: Daratumumab
Drug: Clarithromycin
Drug: Pomalidomide
Drug: Dexamethasone
Drug: Bortezomib
Drug: Dexamethasone
Drug: Lenalidomide
Drug: Acetaminophen
Drug: Diphenhydramine
Drug: Montelukast
Drug: Carfilzomib
Drug: Daratumumab
Biological: Autologous Stem Cell Transplant (ASCT)
Drug: Bortezomib
Drug: Isatuximab
Drug: Cyclophosphamide
Drug: Dexamethasone
Drug: HPN217
Drug: Daratumumab
Drug: Carfilzomib
Drug: Pomalidomide
Drug: Dexamethasone
Biological: RAPA-201 Autologous T cells
Drug: CC-486
Drug: Lenalidomide
Radiation: Radiation Therapy
Drug: CART-ddBCMA
Drug: ARC-T Plus Anti-BCMA SparX
Drug: Elotuzumab, pomalidomide, dexamethasone
Drug: Anti-LAG-3
Drug: Anti-LAG-3 + Pomalidimide + Dexamethasone
Drug: Anti-TIGIT
Drug: Anti-TIGIT + Pomalidimide + Dexamethasone
Biological: UCARTCS1A
Drug: Daratumumab
Drug: Lenalidomide
Drug: Bortezomib
Drug: Dexamethasone
Drug: JNJ-68284528
Drug: Lenalidomide
Drug: Daratumumab
Drug: Bortezomib
Drug: Dexamethasone
Drug: Belantamab mafodotin
Drug: GSK3174998
Drug: Feladilimab
Drug: Nirogacestat
Drug: Dostarlimab
Drug: Isatuximab
Drug: Lenalidomide
Drug: Dexamethasone
Drug: Pomalidomide
Drug: Ixazomib
Drug: Pomalidomide
Drug: Dexamethasone
Genetic: ALLO-715
Biological: ALLO-647
Drug: Fludarabine
Drug: Cyclophosphamide
Drug: Nirogacestat
Drug: Belantamab mafodotin
Drug: Bortezomib
Drug: Lenalidomide
Drug: Dexamethasone
Drug: Lenalidomide
Drug: Daratumumab/rHuPH20
Drug: Daratumumab
Drug: Bortezomib
Drug: Lenalidomide
Drug: Dexamethasone
Drug: Ixazomib
Drug: CC-99712
Drug: BMS-986405
Drug: CYT-0851
Drug: CYT-0851 in combination with gemcitabine
Drug: CYT-0851 in combination with capecitabine
Drug: CYT-0851 in combination with rituximab and bendamustine
Drug: CC-92480
Drug: Bortezomib
Drug: Dexamethasone
Drug: Daratumumab
Drug: Carfilzomib
Drug: Elotuzumab
Drug: Isatuximab
Drug: Carfilzomib
Biological: zevor-cel
Drug: Carfilzomib
Drug: Cyclophosphamide
Drug: Dexamethasone
Drug: Granulocyte Colony-Stimulating Factor
Drug: Daratumumab
Drug: Lenalidomide
Drug: Ketorolac
Drug: Normal saline
Drug: Acetaminophen
Drug: Oxycodone Acetaminophen
Drug: Morphine
Drug: Hydrocodone/Acetaminophen
Drug: Oxycodone
Drug: Carfilzomib
Drug: Busulfan IV
Drug: Melphalan IV
Drug: Ixazomib
Drug: Lenalidomide
Drug: Abemaciclib, dexamethasone, ixazomib, pomalidomide
Drug: Enasidenib, dexamethasone, ixazomib, pomalidomide
Drug: Cobimetinib, dexamethasone, ixazomib, pomalidomide
Drug: Erdafitinib, dexamethasone, ixazomib, pomalidomide
Drug: Venetoclax, dexamethasone, ixazomib, pomalidomide
Drug: Daratumumab, dexamethasone, ixazomib, pomalidomide
Drug: Belantamab mafodotin, dexamethasone, ixazomib, pomalidomide
Drug: Selinexor, dexamethasone, ixazomib, pomalidomide
Drug: Carfilzomib
Drug: Lenalidomide
Drug: Dexamethasone
Drug: Bortezomib
Drug: Ibrutinib
Drug: Lenalidomide
Drug: Dexamethasone
Drug: CAR138 T Cells
Other: Ascorbate
Drug: Melphalan
Biological: bb2121
Drug: Lenalomide
Drug: Allopurinol
Drug: Carmustine
Drug: Etoposide
Drug: Cytarabine
Drug: Melphalan
Drug: Pomalidomide
Drug: Dexamethasone
Drug: Venetoclax
Drug: TTI-622
Drug: Azacitidine
Drug: Venetoclax
Drug: Carfilzomib
Drug: Dexamethasone
Drug: Anti-CD20 Targeting agent
Drug: Isatuximab
Drug: Daratumumab
Drug: Carfilzomib
Drug: Lenalidomide
Drug: Dexamethasone
Drug: CC-93269
Drug: Cyclophosphamide
Drug: Fludarabine
Drug: Aldesleukin
Biological: Individual Patient TCR-Transduced PBL
Drug: Pembrolizumab (KEYTRUDA )
Drug: CC-92480
Drug: Dexamethasone
Biological: HSCT with TBI Regimen
Biological: HSCT with Non-TBI Regimen
Biological: ISB 1342
Drug: Cevostamab
Drug: Tocilizumab
Drug: Modakafusp alfa
Drug: Dexamethasone
Drug: Evomela
Drug: Fludarabine
Radiation: Total Body Irradiation
Drug: Ruxolitinib Oral Tablet [Jakafi]
Drug: Lenalidomide
Drug: Methylprednisolone
Radiation: Total Body Irradiation 1200 cGy
Radiation: Total Body Irradiation 200 cGy
Drug: Cyclophosphamide
Drug: Mesna
Procedure: Cord Blood Infusion
Drug: Busulfan
Drug: Fludarabine
Drug: Melphalan
Drug: Iopofosine I 131 single dose
Drug: Iopofosine I 131 multiple dose
Drug: Iopofosine I 131 fractionated dose
Drug: Carfilzomib
Drug: Venetoclax
Drug: Dexamethasone
Drug: CC-220
Drug: Dexamethasone
Drug: Daratumumab
Drug: Bortezomib
Drug: Carfilzomib
Drug: Palbociclib
Drug: Sunitinib
Drug: Temsirolimus
Drug: Trastuzumab and Pertuzumab
Drug: Vemurafenib and Cobimetinib
Drug: Regorafenib
Drug: Olaparib
Drug: Pembrolizumab
Drug: Nivolumab and Ipilimumab
Drug: Abemaciclib
Drug: Talazoparib
Drug: Atezolizumab and PHESGO
Drug: Atezolizumab and Talazoparib
Drug: Entrectinib
Drug: Larotrectinib
Drug: Tucatinib plus Trastuzumab Subcutaneous (SC)
Drug: Futibatinib
Drug: AMG 176
Drug: Azacitidine
Drug: Itraconazole
Drug: KPT-8602
Drug: ASTX727
Drug: Dexamethasone
Biological: Rituximab
Drug: Conditioning chemotherapy
Drug: TMS
Drug: FLAG
Drug: EPOCH-F
Procedure: Hematopoietic stem cell transplant
Drug: Palifermin
Biological: Isatuximab
Drug: Carfilzomib
Drug: Dexamethasone
Biological: TAA-specific CTLs
Biological: TAA-specific CTLs- fixed dose
Drug: selinexor
Drug: carfilzomib
Drug: dexamethasone
Drug: Fludarabine
Drug: Cyclophosphamide
Radiation: Total Body Irradiation
Drug: Cyclosporine A
Drug: Mycophenylate mofetil
Biological: Umbilical cord blood
Procedure: Haploidentical Bone Marrow/Kidney
Drug: Pomalidomide
Drug: Carfilzomib
Drug: dexamethasone
Drug: Daratumumab
Subscribe to the weekly "HealthTree Community for Myeloma Newsletter" for Myeloma news, life with Myeloma stories, Myeloma clinical trials, Myeloma 101 articles and events with Myeloma experts.